Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.2 EUR | +0.30% | -0.81% | +15.97% |
05-30 | Merck KGaA: memorandum of understanding with South Korean institute | CF |
05-30 | Merck KGaA Signs Korea Science Research Pact | DJ |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With a 2024 P/E ratio at 24 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- With an enterprise value anticipated at 3.68 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.97% | 78.51B | - | ||
+12.05% | 9B | A- | ||
+58.17% | 4.96B | - | ||
-14.94% | 4.84B | A- | ||
-.--% | 3.72B | B- | ||
+21.94% | 2.48B | B | ||
-26.63% | 2.19B | C- | ||
+16.75% | 2.12B | - | - | |
-37.97% | 1.94B | - | ||
-0.50% | 1.64B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MRK Stock
- MRK Stock
- Ratings Merck KGaA